Thursday, 20 Feb 2020

You are here

Study Looks at Opioid Use After Knee Surgery

A small study looked at whether reducing the number of opioid tablets prescribed after knee surgery would reduce postoperative use and if preoperative opioid-use education would reduce it even more.

The study included 264 patients who underwent anterior cruciate ligament (ACL) surgery at a single academic ambulatory surgery center. They were divided into three groups: 109 were prescribed 50 opioid tablets after surgery; 78 patients were prescribed 30 tablets and before surgery received education on appropriate opioid use and alternative pain control strategies; and 77 patients received 30 tablets and no education.

Patients were surveyed about their opioid use three weeks after surgery. Researchers report patients who received 50 tablets consumed more tablets (an average of 25) and for more days (nearly 6) than those given 30 tablets and no education who consumed less (an average of about 16) and for fewer days (about 4½). Patients who received 30 tablets and preoperative education used fewer tablets (average of about 12) and for fewer days (about 3½) than patients who received 30 tablets but no opioid use education.

A limitation of the study to consider is that was conducted at just one surgery center and the patient group was young.

Add new comment

More Like This

Half of Opioids Rx Come from 1% of MDs

The BMJ reports that while most US providers are cautious in their prescribing, half of opioid prescriptions are written by 1% of providers.

Between 2003 and 2017, there was an annual average of 669495 providers prescribing 8.9 million opioid prescriptions.

In 2017, 1% of providers accounted for 49% of all opioid doses and 27% of all opioid prescriptions; that's nearly 1000 times more than the middle 1% of prescribers.

Domestic Abuse Linked to Fibromyalgia and Chronic Fatigue

Domestic violence was found to predispose to a higher risk of fibromyalgia and those developing chronic fatigue syndrome.

Researchers studied the association between intimate partner violence (IPV) with fibromyalgia and CFS, using a retrospective open cohort design of patients entered into the “The Heath Improvement Network” database between 1995 and 2017.

A Potential Biomarker for Chronic Fatigue Syndrome Patients

Myalgic encephalomyelitis/chronic fatigue syndrome affects at least 2 million people in the United States and bears tremendous overlap with fibromyalgia - both being difficult to diagnosis because the symptom complex is often unrecognized and these conditions have no biomarker test. 

NIH Conference Review of Chronic Fatigue Syndrome

The current issue of JAMA reviews recent advances on chronic fatigue syndrome, also known as myalgic encephalomyelitis/(ME/CFS), based on a 2-day conference held at the NIH in an April 2019. The NIH 2-day conference reviewed recent progress and new research in several areas described below.

Gabapentinoid Drugs Overuse and Misuse

A recent article in JAMA by Drs. Goodman and Brett reviews the increasing off label use of gabapentinoid drugs, originally developed as antiseizure drugs that are now increasingly prescribed for painful conditions.